Abdominal Aortic Aneurysm — Complementary and Alternative Medicine Interventions in Targeting Pain
Citation(s)
Bagby RM, Parker JD, Taylor GJ The twenty-item Toronto Alexithymia Scale--I. Item selection and cross-validation of the factor structure. J Psychosom Res. 1994 Jan;38(1):23-32.
Bagby RM, Taylor GJ, Parker JD The Twenty-item Toronto Alexithymia Scale--II. Convergent, discriminant, and concurrent validity. J Psychosom Res. 1994 Jan;38(1):33-40.
Casey A, Chang BH, Huddleston J, Virani N, Benson H, Dusek JA A model for integrating a mind/body approach to cardiac rehabilitation: outcomes and correlators. J Cardiopulm Rehabil Prev. 2009 Jul-Aug;29(4):230-8; quiz 239-40. doi: 10.1097/HCR.0b013e3181a33352.
Chang BH, Casey A, Dusek JA, Benson H Relaxation response and spirituality: Pathways to improve psychological outcomes in cardiac rehabilitation. J Psychosom Res. 2010 Aug;69(2):93-100. doi: 10.1016/j.jpsychores.2010.01.007. Epub 2010 Mar 1.
Craparo G, Faraci P, Rotondo G, Gori A The Impact of Event Scale - Revised: psychometric properties of the Italian version in a sample of flood victims. Neuropsychiatr Dis Treat. 2013;9:1427-32. doi: 10.2147/NDT.S51793. Epub 2013 Sep 19.
Faul F, Erdfelder E, Lang AG, Buchner A G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007 May;39(2):175-91.
Glaros AG, Lumley MA Alexithymia and pain in temporomandibular disorder. J Psychosom Res. 2005 Aug;59(2):85-8.
Horowitz M, Wilner N, Alvarez W Impact of Event Scale: a measure of subjective stress. Psychosom Med. 1979 May;41(3):209-18.
Jensen MP, McFarland CA Increasing the reliability and validity of pain intensity measurement in chronic pain patients. Pain. 1993 Nov;55(2):195-203. doi: 10.1016/0304-3959(93)90148-I.
Jensen MP, Moore MR, Bockow TB, Ehde DM, Engel JM Psychosocial factors and adjustment to chronic pain in persons with physical disabilities: a systematic review. Arch Phys Med Rehabil. 2011 Jan;92(1):146-60. doi: 10.1016/j.apmr.2010.09.021. Review.
Johnson C Measuring Pain. Visual Analog Scale Versus Numeric Pain Scale: What is the Difference? J Chiropr Med. 2005 Winter;4(1):43-4. doi: 10.1016/S0899-3467(07)60112-8.
Olssøn I, Mykletun A, Dahl AA The Hospital Anxiety and Depression Rating Scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry. 2005 Dec 14;5:46.
Rodriguez CS Pain measurement in the elderly: a review. Pain Manag Nurs. 2001 Jun;2(2):38-46. Review.
Schubart JR, Mitchell AJ, Dietrich L, Gusani NJ Accuracy of the Emotion Thermometers (ET) screening tool in patients undergoing surgery for upper gastrointestinal malignancies. J Psychosoc Oncol. 2015;33(1):1-14. doi: 10.1080/07347332.2014.977415.
Tuzer V, Bulut SD, Bastug B, Kayalar G, Göka E, Bestepe E Causal attributions and alexithymia in female patients with fibromyalgia or chronic low back pain. Nord J Psychiatry. 2011 Apr;65(2):138-44. doi: 10.3109/08039488.2010.522596. Epub 2010 Sep 27.
Villemure C, Bushnell CM Cognitive modulation of pain: how do attention and emotion influence pain processing? Pain. 2002 Feb;95(3):195-199. doi: 10.1016/S0304-3959(02)00007-6. Review.
Zigmond AS, Snaith RP The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70.
Complementary and Alternative Medicine Interventions in Targeting Pain
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.